Company news
Shattuck Labs, Inc. news in 2024
Shattuck Labs, Inc.'s news releases, calls and decks from 2024, newest first.
Shattuck Labs Announces Participation in Upcoming December Conferences
November 24, 2024
Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 13, 2024
Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway
September 30, 2024
Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights
July 31, 2024
Shattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology Conference
July 29, 2024
Shattuck Labs Announces Addition to Russell 2000® and Russell 3000® Indexes
June 30, 2024
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid...
June 13, 2024
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)
June 9, 2024
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 1, 2024
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
April 8, 2024
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
March 31, 2024
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
March 3, 2024
Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
February 28, 2024
Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases
February 12, 2024
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024
January 7, 2024
Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
January 3, 2024